ITEMS IN AFP WITH KEYWORD:
Chronic Obstructive Pulmonary Disease
Exacerbations of chronic obstructive pulmonary disease contribute to the high mortality rate associated with the disease. Randomized controlled trials have demonstrated the effectiveness of multiple interventions. The first step in outpatient management should be to increase the dosage of inhaled sh...
Oct 15, 2009 Issue
Screening for Chronic Obstructive Pulmonary Disease Using Spriometry [Putting Prevention into Practice]
Case study: A 50-year-old woman presents for a routine check-up and medication refills. She has smoked a pack of cigarettes daily for more than 30 years but does not report chest pain or breathing problems.
Oct 15, 2009 Issue
Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends against screening adults for chronic obstructive pulmonary disease (COPD) using spirometry.
Aug 1, 2008 Issue
ACP Guideline Recommends Diagnosis and Management Strategies for COPD [Practice Guidelines]
The American College of Physicians (ACP) has released a guideline providing recommendations on the diagnosis and treatment of chronic obstructive pulmonary disease (COPD).
Chronic obstructive pulmonary disease affects more than 26 million adults in the United States. Family physicians provide care for most of these patients. Cigarette smoking is the leading risk factor for chronic obstructive pulmonary disease, although other risk factors, including occupational and e...
Jun 1, 2008 Issue
Use of Inhaled Corticosteroids to Treat Stable COPD [Cochrane for Clinicians]
Although the use of inhaled corticosteroids for COPD will not reduce mortality or affect long-term disease progression, inhaled corticosteroids can be useful for reducing COPD exacerbations and slowing declines in quality of life.
Is fluticasone plus salmeterol better than fluticasone or salmeterol alone for treating patients with COPD? Anticholinergics are the bronchodilators of choice. Neither fluticasone nor the combination of fluticasone and salmeterol were no better than placebo at preventing mortality.
Chronic obstructive pulmonary disease (COPD) is a common problem among patients presenting to primary care. This condition has multiple individual and combined treatment regimens. The goals of treatment are to improve quality of life, exercise tolerance, sleep quality, and survival; and to reduce dy...
In 20 studies of cardioselective beta blockers in patients with COPD, participants had no adverse pulmonary or respiratory effects. Because of their salutary cardiovascular effects, cardioselective beta blockers should not be withheld from patients with COPD.
There is consistent evidence from a small number of studies that antibiotics significantly reduce mortality (number needed to treat [NNT] = 8) and treatment failure (NNT = 3) in more severely ill patients with COPD who are hospitalized because of an exacerbation. Two smaller studies found no benefit...